FDA OKs Novoste's dialysis graft stenosis trial:
This article was originally published in Clinica
Executive Summary
The US FDA has given Novoste the go-ahead to start a clinical trial of its CORONA catheter-based radiation system for treating stenoses in arterial-venous dialysis grafts. The BRAVO trial is a prospective, randomised, multicentre, placebo-controlled study, which will enrol around 230 patients at over 20 centres in North America and Europe, said the Atlanta, Georgia firm.